Capstone Holding Corp. (CAPS)
| Market Cap | 12.98M |
| Revenue (ttm) | 44.05M |
| Net Income (ttm) | -5.64M |
| Shares Out | 5.19M |
| EPS (ttm) | -35.80 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100 |
| Average Volume | 20 |
| Open | 2.500 |
| Previous Close | 2.500 |
| Day's Range | 2.500 - 2.500 |
| 52-Week Range | 2.240 - 16.180 |
| Beta | -0.64 |
| RSI | 37.31 |
| Earnings Date | Apr 2, 2025 |
About Capstone Holding
Capstone Holding Corp., through its subsidiary, TotalStone, LLC, engages in the distribution of masonry stone products in the Midwest and Northeast United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products, and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. The company was incorporated in 1987 and is based in Alsip, Illinois. Capstone... [Read more]
Financial Performance
In 2023, Capstone Holding's revenue was $48.35 million, a decrease of -21.45% compared to the previous year's $61.56 million. Losses were -$5.74 million, 57250.0% more than in 2022.
Financial StatementsNews
U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings
Two small IPOs listed this week - INLIF and OneConstruction Group. Five issuers and two SPACs submitted initial filings this week. The 2025 IPO market is here, and while there are a few small deals on...
Capstone Holding Corp. Announces CEO Change
ALSIP, IL / ACCESSWIRE / December 9, 2024 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 2, 2024, Michael Toporek resigned in good standing as CEO of the Company and will con...
Capstone Holding Corp. Reinstates Tax Benefit Plan
ALSIP, IL / ACCESSWIRE / May 3, 2024 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") On May 1, 2024, the Board of Directors (the "Board") of Capstone Holding Corp. (the "Company") authorized and...
Capstone Holding Corp. Announces Change in Board of Directors
ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elw...
Capstone Holding Corp. Announces Change of Equity Ownership in Diamond Products Holding, LLC
ALSIP, IL / ACCESSWIRE / November 21, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective November 16, 2023, the Company reached agreement to revise its accounting treatment for Capst...
Capstone Holding Corp. Announces CFO Change
ALSIP, IL / ACCESSWIRE / August 28, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective August 25, 2023, Omar Rabbani resigned in good standing as Chief Financial Officer of the Compa...
Capstone Therapeutics Corp. Announces Results Of Annual Meeting
ALSIP, IL / ACCESSWIRE / March 6, 2023 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company") The Annual Meeting of Stockholders of Capstone Therapeutics Corp., a Delaware corporation, was held on...
Capstone Therapeutics Corp. Announces Results of Annual Meeting
ALSIP, IL / ACCESSWIRE / March 7, 2023 / Capstone Therapeutics Corp. (OTCQB: CAPS) ("the Company") The Annual Meeting of Stockholders of Capstone Therapeutics Corp., a Delaware corporation, was held o...
Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
ALSIP, IL / ACCESSWIRE / June 21, 2022 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON ...
Capstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.
ALSIP, IL / ACCESSWIRE / February 25, 2022 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company"), The Company is please to announce a name change effective on this date to Capstone Holding Corp. ...
Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control
ALSIP, IL / ACCESSWIRE / December 28, 2020 / Capstone Therapeutics (OTCQB:CAPS) ("the Company"): EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 24,900 SHARES OF THE COMPANY'S COM...